Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma

Overview of attention for article published in Oncologist, March 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (81st percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 28,877 followers.

RT @OncJournal: Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refracto…

Avelumab, a PD‐L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma #Avelumab #Radiotherapy #AbscopalEffect #MultipleMyeloma #ClinicalTrialResults https://t.co/WiKGeAoUHR https://…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.